There are now four Molnupiravir-based drugs  produced in Vietnam approved for domestic use. (Photo: suckhoedoisong.vn)

This is the fourth Molnupiravir-based drug produced in Vietnam to be authorised for use in the country.
The DAV orders manufacturers to adhere to documents registered with the Ministry of Health; coordinate with treatment facilities to strictly comply with current regulations on prescription drugs, monitor the safety, effectiveness, and unwanted effects of drugs on Vietnamese people, as well as compile reports according to regulations.
At the same time, the DAV also requested local departments of health notify medical examination and treatment facilities, medical staff, and drug suppliers in the area to inform patients of the benefits and risks when using Molnupiravir, including treatments, as well as alternatives for Molnupiravir in the treatment of COVID-19. 
In addition, it requires units to strengthen monitoring, supervision and detection of cases of adverse drug reactions (if any), to send reports to the National Center for Drug Information and Adverse Drug Reaction Monitoring (Hanoi) or Regional Center for Drug Information and Adverse Drug reaction monitoring (Ho Chi Minh City), according to regulations.